Afatinib Dimaleate 50 mg (Generic)

What is Afatinib Dimaleate 50 mg?

Afatinib Dimaleate 50 mg is a prescription medication formulated specifically for the treatment of certain types of cancer, primarily non-small cell lung cancer (NSCLC). Manufactured by Boehringer Ingelheim India Pvt.Ltd, this medicine has gained recognition for its targeted approach in managing cancer cells resistant to other therapies.

Essentially, Afatinib Dimaleate is an oral drug that belongs to a class known as tyrosine kinase inhibitors. It works by blocking specific proteins that promote cancer cell growth and spread, helping to slow down disease progression. This mode of action distinguishes it from traditional chemotherapy, offering a more focused treatment with potentially fewer systemic effects.

Used under strict medical supervision, Afatinib Dimaleate 50 mg is suited for patients diagnosed with non-small cell lung cancer that has specific genetic mutations. Its development marks a significant advancement in personalized cancer therapy, offering new hope to many patients globally, including those in Malaysia.

Uses of Afatinib Dimaleate 50 mg

• Treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations
• Management of NSCLC in patients who have developed resistance to other EGFR inhibitors
• Targeted therapy to inhibit cancer cell growth and proliferation

How Afatinib Dimaleate 50 mg Works

Afatinib Dimaleate 50 mg functions by selectively and irreversibly blocking the activity of the epidermal growth factor receptor (EGFR) family of tyrosine kinases. These receptors are often overexpressed or mutated in cancer cells, driving uncontrolled growth and survival.

By inhibiting these receptors, Afatinib disrupts the signaling pathways necessary for cancer cell multiplication, thereby slowing or stopping tumor growth. This targeted mechanism minimizes damage to normal cells, differentiating it from more generalized chemotherapy treatments.

How to take Afatinib Dimaleate 50 mg

Afatinib Dimaleate 50 mg is administered orally, usually once daily with or without food. It is important to take the medication at the same time each day to maintain consistent drug levels in your body.

Swallow the tablet whole with water without crushing or chewing it. Follow the dosage and schedule prescribed by your physician carefully. Do not alter the dose or discontinue the medication without consulting your healthcare provider, as this might affect the treatment’s effectiveness and safety.

Benefits of Afatinib Dimaleate 50 mg

• Offers targeted treatment for EGFR-mutated non-small cell lung cancer
• Potential to slow cancer progression with fewer side effects compared to traditional chemotherapy
• Oral administration provides convenience and ease of use
• May improve overall quality of life and survival rates in certain patients

Dosage and Administration

The recommended dose of Afatinib Dimaleate 50 mg is typically one 50 mg tablet once daily. Dosage may be adjusted based on individual tolerance, side effects, and clinical response. Dose reductions to 40 mg or 30 mg may be necessary if adverse reactions occur.

Patients should have regular monitoring through clinical evaluation and laboratory tests to assess response and detect side effects early. The duration of treatment depends on the patient's condition and physician’s assessment.

Who Should Use Afatinib Dimaleate 50 mg?

Afatinib Dimaleate 50 mg is prescribed for adult patients diagnosed with non-small cell lung cancer harboring sensitive EGFR mutations. It is most suitable for those who have not responded effectively to other EGFR inhibitor treatments or where an irreversible inhibitor is considered optimal.

Before starting, patients should undergo molecular testing to confirm the presence of EGFR mutations to ensure suitability. Close medical supervision is essential during treatment.

Who Should Avoid Afatinib Dimaleate 50 mg?

Patients with known hypersensitivity to Afatinib Dimaleate or its excipients should avoid this medication. It is not recommended for use in individuals without confirmed EGFR mutation status.

Pregnant or breastfeeding women should avoid the drug due to potential harm to the fetus or infant. Patients with severe liver or kidney impairment should use caution or avoid use depending on medical advice. Additionally, those with uncontrolled infections or other serious medical conditions should discuss alternative therapies with their physician.

Side Effects of Afatinib Dimaleate 50 mg

• Diarrhea
• Skin rash
• Dry skin
• Mouth sores
• Nausea
• Vomiting
• Fatigue
• Decreased appetite
• Stomatitis (inflammation of the mouth)
• Paronychia (nail infection)
• Eye irritation
• Elevated liver enzymes

Safety Advice

• Inform your doctor about all medications and supplements you are taking to avoid interactions
• Report any unusual or severe side effects immediately
• Do not skip doses or stop medication without medical consultation
• Use effective contraception during treatment to prevent pregnancy
• Attend all scheduled medical appointments for monitoring
• Maintain adequate hydration and manage diarrhea promptly

Drug Interactions

• CYP3A4 inducers like rifampicin may reduce Afatinib effectiveness
• Drugs that affect stomach acidity, such as antacids, can alter absorption
• Co-administration with P-glycoprotein inhibitors may increase Afatinib plasma levels
• Other cancer therapies may interact and require careful assessment

Storage Instructions

Store Afatinib Dimaleate 50 mg tablets at room temperature between 20°C to 25°C. Keep the medication in its original packaging, away from moisture and direct sunlight. Ensure that it is stored safely out of reach of children and pets.

Where to buy Afatinib Dimaleate 50 mg in Malaysia?

Afatinib Dimaleate 50 mg can be purchased at licensed pharmacies and authorized medical suppliers throughout Malaysia. It is essential to buy this medication with a prescription from a qualified oncologist or healthcare provider.

Patients are advised to avoid unauthorized sellers or online platforms that may offer counterfeit products. For best results and safety, purchasing through official channels ensures authenticity and proper handling of the medicine.

Frequently Asked Questions (FAQ)

What is the price of Afatinib Dimaleate 50 mg in Malaysia?

The price of Afatinib Dimaleate 50 mg varies depending on the supplier and pharmacy. Patients should consult local pharmacies or healthcare providers for the most accurate and updated pricing information.

What happens if I miss a dose?

If you miss a dose of Afatinib Dimaleate 50 mg, take it as soon as you remember unless it is near the time of your next dose. Do not double the dose to make up for the missed one. Contact your doctor if you miss multiple doses.

Where can I find Afatinib Dimaleate 50 mg for sale?

You can find Afatinib Dimaleate 50 mg at licensed pharmacies, hospital pharmacies, and through authorized medical distributors in Malaysia. Always ensure you have a valid prescription before purchasing.

Is Afatinib Dimaleate 50 mg available in Malaysia?

Yes, Afatinib Dimaleate 50 mg is available in Malaysia through prescription and is supplied by authorized manufacturers and distributors such as Boehringer Ingelheim India Pvt.Ltd.

Can Afatinib Dimaleate 50 mg be taken with food?

Afatinib Dimaleate 50 mg can be taken with or without food. However, taking it consistently in the same manner daily may help maintain stable drug levels in your body.

How long does it take for Afatinib Dimaleate 50 mg to work?

The response time varies by individual; some patients may notice improvements within weeks, but ongoing treatment and regular monitoring are essential to assess effectiveness.

Are there any specific diet or lifestyle restrictions while on Afatinib Dimaleate 50 mg?

There are no strict dietary restrictions, but maintaining good hydration and managing side effects such as diarrhea or mouth sores with dietary adjustments can improve comfort during treatment.

New

This medication is used specifically for targeted treatment of certain lung cancers.

New

Consult your healthcare provider regularly to monitor health during therapy.

New

Always source Afatinib Dimaleate 50 mg from trusted suppliers.

Conclusion

Afatinib Dimaleate 50 mg represents a critical advancement in the management of non-small cell lung cancer by offering targeted, effective treatment options. Its ability to inhibit cancer cell growth with a defined mechanism helps patients achieve better outcomes while managing safety concerns diligently. Through proper medical guidance, adherence to dosage, and awareness of side effects and interactions, patients in Malaysia can benefit from this innovative therapy to fight lung cancer with greater confidence.